Kory Wentworth
Finanzdirektor/CFO bei ENTRADA THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Kory Wentworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.11.2020 | - |
| Treasurer | 01.11.2020 | - |
Karriereverlauf von Kory Wentworth
Ehemalige bekannte Positionen von Kory Wentworth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Comptroller/Controller/Auditor | 18.12.2017 | 08.09.2020 |
| Treasurer | 18.12.2017 | 02.10.2020 | |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.11.2017 | 01.12.2017 |
| Direktor/Vorstandsmitglied | 01.01.2012 | 01.12.2017 | |
| Corporate Officer/Principal | 01.12.2008 | 01.12.2017 |
Ausbildung von Kory Wentworth
| Susquehanna University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Treasurer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| ENTRADA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Kory Wentworth
- Erfahrung
